Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Pharmacies & Pharmacy Benefit Managers

Overview

Pharmacies and pharmacy benefit management services play an invaluable role in the delivery of care and represent a significant and growing share of the health care economy. We provide legal, regulatory, and government advocacy services to help you thrive in this complex industry and evolve with the changing business and regulatory landscape. From commercial contracting and strategic transactional matters to licensing and other state and federal regulatory support, we represent stakeholders across the pharmacy and pharmacy benefit manager (PBM) continuum on day-to-day challenges and help them advance their long-term goals.
Our team works at the forefront of pharmacy and prescription drug policy at the state and federal levels. We partnered with stakeholders to advocate for passage of the Drug Supply Chain Security Act (DSCSA) and the Ryan Haight Act, and we work with organizations pursuing policy initiatives on pharmacy services and prescription drug-related federal and state laws. As the drug distribution system and related coverage and reimbursement dynamics continue to evolve, we leverage our knowledge of emerging trends to help you stay ahead of the curve.

Insights & Events

Latest

Updates October 2026

Federal Health Policy Landscape: What Might Happen during the Lame Duck Congress?

For those looking to advance measures to passage, active and sustained engagement will be necessary.
7 min read
Speaking Engagement Recap September 23, 2026

Johns Hopkins Bloomberg School of Public Health’s 2026 BESAFE Conference

Johns Hopkins Bloomberg School of Public Health
1 min read
News September 2026

Faegre Drinker Advises ASOP Global Foundation on Launch of Rx Watchdog Platform Monitoring Unsafe Online Pharmaceutical Sales

2 min read
Press Release September 2026

Health and Pharmaceutical Compliance Attorney Lindsay Holmes Joins Faegre Drinker in Washington, D.C.

2 min read
Media Mentions July 2026

Libby Baney Burstein Discusses Risks Associated with PBM Cost-Containment Strategies in Modern Healthcare

1 min read
Updates March 2026

Access through Innovation with Amazon Pharmacy

Digital Health “From the Inside Out” Leadership Series
2 min read
Updates March 2026

FDA Finalizes Rule Requiring 12-Digit National Drug Code (NDC)

Two Little Digits, One Very Big Operational Headache
4 min read
Updates February 2026

US and International Developments in Artificial Intelligence

Artificial Intelligence Briefing
6 min read
Updates November 2025

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

And What Opportunities May Lie Ahead?
5 min read
Speaking Engagement Recap November 07, 2025

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Insights
Updates October 2026

Federal Health Policy Landscape: What Might Happen during the Lame Duck Congress?

For those looking to advance measures to passage, active and sustained engagement will be necessary.
7 min read
Media Mentions July 2026

Libby Baney Burstein Discusses Risks Associated with PBM Cost-Containment Strategies in Modern Healthcare

1 min read
Updates March 2026

Access through Innovation with Amazon Pharmacy

Digital Health “From the Inside Out” Leadership Series
2 min read
Updates March 2026

FDA Finalizes Rule Requiring 12-Digit National Drug Code (NDC)

Two Little Digits, One Very Big Operational Headache
4 min read
Updates February 2026

US and International Developments in Artificial Intelligence

Artificial Intelligence Briefing
6 min read
Updates November 2025

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

And What Opportunities May Lie Ahead?
5 min read
Published Articles October 2025

'Most-Favored Nation' Drug Pricing: Impacts on the Pharmacy Supply Chain

National Association of Boards of Pharmacy’s Innovations
1 min read
Updates August 2025

Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More

Biopharma & Medical Devices Briefing
7 min read
Updates June 2025

Insurance Regulatory Considerations for Prescription Drug Cost-Management Programs

The Consequences of Engaging in the Unlicensed Business of Insurance Can Be Severe
6 min read
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read